Voyageur Pharmaceuticals Stock Today
| VM Stock | CAD 0.18 0.01 5.26% |
PerformanceGood
| Odds Of DistressBelow Average
|
Voyageur Pharmaceuticals is selling for under 0.18 as of the 16th of February 2025; that is 5.26 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.18. Voyageur Pharmaceuticals has about a 30 percent probability of financial distress in the next few years of operation but had a somewhat good performance during the last 90 days. The performance scores are derived for the period starting the 17th of January 2025 and ending today, the 16th of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Voyageur Minerals Ltd., an exploration stage company, engages in acquiring, exploring, and developing mineral exploration properties. The company also has interests in the Paradox Basin and Lithium King lithium brine projects in Utah. VOYAGEUR MINERALS operates under Industrial Metals Minerals classification in Canada and is traded on TSX Venture Exchange.. The company has 147.75 M outstanding shares of which 646.21 K shares are at this time shorted by private and institutional investors with about 0.57 trading days to cover. More on Voyageur Pharmaceuticals
Moving together with Voyageur Stock
Moving against Voyageur Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Voyageur Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Voyageur Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Voyageur Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | Brent BscEng | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Industrial Metals & Minerals, Basic Materials (View all Sectors) | ||||
Voyageur Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Voyageur Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsVoyageur Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Voyageur Pharmaceuticals' financial leverage. It provides some insight into what part of Voyageur Pharmaceuticals' total assets is financed by creditors.
| |||||
Voyageur Pharmaceuticals (VM) is traded on TSX Venture Exchange in Canada and employs 5 people. Voyageur Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 26.6 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Voyageur Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Voyageur Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Voyageur Pharmaceuticals conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 147.75 M outstanding shares of which 646.21 K shares are at this time shorted by private and institutional investors with about 0.57 trading days to cover.
Voyageur Pharmaceuticals currently holds about 27.59 K in cash with (991.25 K) of positive cash flow from operations.
Check Voyageur Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationVoyageur Pharmaceuticals shows a total of 147.75 Million outstanding shares. Voyageur Pharmaceuticals has 8.9 % of its outstanding shares held by insiders and 0.0 % owned by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Voyageur Ownership Details
Voyageur Pharmaceuticals Risk Profiles
Although Voyageur Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Voyageur Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 7.51 | |||
| Semi Deviation | 6.93 | |||
| Standard Deviation | 12.09 | |||
| Variance | 146.05 |
Voyageur Stock Against Markets
| VM | 5.26 |
|
| Compare Correlations |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Voyageur Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
Voyageur Pharmaceuticals Corporate Management
Elected by the shareholders, the Voyageur Pharmaceuticals' board of directors comprises two types of representatives: Voyageur Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Voyageur. The board's role is to monitor Voyageur Pharmaceuticals' management team and ensure that shareholders' interests are well served. Voyageur Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Voyageur Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Albert Deslauriers | Chief Officer | Profile | |
| Iryna MD | Chief Officer | Profile | |
| Bradley PEng | COO Founder | Profile | |
| Ethan Mohan | Sales Manager | Profile |
Additional Tools for Voyageur Stock Analysis
When running Voyageur Pharmaceuticals' price analysis, check to measure Voyageur Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Voyageur Pharmaceuticals is operating at the current time. Most of Voyageur Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Voyageur Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Voyageur Pharmaceuticals' price. Additionally, you may evaluate how the addition of Voyageur Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.